MFS
Mirabella Financial Services Portfolio holdings
AUM
$953M
1-Year Return
26.75%
This Quarter Return
+3.48%
1 Year Return
+26.75%
3 Year Return
+90.29%
5 Year Return
+169.53%
10 Year Return
–
AUM
$360M
AUM Growth
-$13.9M
(-3.7%)
Cap. Flow
-$33.5M
Cap. Flow
% of AUM
-9.32%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
446
New
281
Increased
28
Reduced
39
Closed
95
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$11.4M |
| 2 |
Fortive
FTV
|
$10.6M |
| 3 |
SPDR S&P Homebuilders ETF
XHB
|
$7.88M |
| 4 |
American Electric Power
AEP
|
$7.75M |
| 5 |
Keurig Dr Pepper
KDP
|
$7.55M |
Top Sells
| 1 |
BGC Group
BGC
|
$38.6M |
| 2 |
First Bancorp
FBP
|
$38.5M |
| 3 |
Ambac
AMBC
|
$24.3M |
| 4 |
OFG Bancorp
OFG
|
$24.1M |
| 5 |
PayPal
PYPL
|
$9.3M |
Sector Composition
| 1 | Financials | 18.72% |
| 2 | Healthcare | 14.98% |
| 3 | Technology | 13.44% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kimberly-Clark
KMB
$43.1B
| $546K | 0.07% |
+3,697
| New | +$546K |
|
127
PNC Financial Services
PNC
$80.5B
| $545K | 0.07% |
+4,959
| New | +$545K |
|
128
Celldex Therapeutics
CLDX
$1.52B
| $535K | 0.07% |
+36,087
| New | +$535K |
|
129
Beam Therapeutics
BEAM
$2.11B
| $534K | 0.07% |
+21,693
| New | +$534K |
|
130
Carvana
CVNA
$50.9B
| $533K | 0.07% |
+2,390
| New | +$533K |
|
131
Revolution Medicines
RVMD
$7.57B
| $532K | 0.07% |
+15,282
| New | +$532K |
|
132
Bristol-Myers Squibb
BMY
$96B
| $529K | 0.07% |
8,770
+2,696
| +44% | +$163K |
|
|
LVGO
133
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $511K | 0.07% |
+3,650
| New | +$511K |
|
134
Prudential Financial
PRU
$37.2B
| $506K | 0.07% |
+7,973
| New | +$506K |
|
135
Commerce Bancshares
CBSH
$8.08B
| $500K | 0.07% |
+11,330
| New | +$500K |
|
136
Immunovant
IMVT
$2.99B
| $500K | 0.07% |
+14,202
| New | +$500K |
|
137
Eversource Energy
ES
$23.6B
| $495K | 0.07% |
+5,928
| New | +$495K |
|
138
Clorox
CLX
$15.5B
| $492K | 0.07% |
+2,343
| New | +$492K |
|
139
Kymera Therapeutics
KYMR
$3.11B
| $489K | 0.07% |
+15,132
| New | +$489K |
|
140
Old Republic International
ORI
$10.1B
| $489K | 0.07% |
+33,165
| New | +$489K |
|
141
Harmony Biosciences
HRMY
$2.07B
| $482K | 0.07% |
+14,232
| New | +$482K |
|
|
SWTX
142
DELISTED
SpringWorks Therapeutics
SWTX
| $474K | 0.07% |
+9,936
| New | +$474K |
|
143
Polaris
PII
$3.33B
| $469K | 0.06% |
+4,976
| New | +$469K |
|
144
Quince Therapeutics
QNCX
$86.5M
| $469K | 0.06% |
+9,375
| New | +$469K |
|
145
Microsoft
MSFT
$3.68T
| $468K | 0.06% |
2,225
-1,661
| -43% | -$349K |
|
146
Vaxcyte
PCVX
$4.29B
| $466K | 0.06% |
+9,432
| New | +$466K |
|
147
Delta Air Lines
DAL
$39.9B
| $462K | 0.06% |
+15,111
| New | +$462K |
|
|
KLRS
148
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $462K | 0.06% |
+730
| New | +$462K |
|
149
KeyCorp
KEY
$20.8B
| $460K | 0.06% |
+38,549
| New | +$460K |
|
150
New Fortress Energy
NFE
$672M
| $456K | 0.06% |
+10,359
| New | +$456K |
|